American Century Companies’s Praxis Precision Medicines PRAX Stock Holding History

American Century Companies's PRAX Position: Q1 2026 in Review

American Century Companies increased its Praxis Precision Medicines (PRAX) stake by 70% in Q1 2026, buying an estimated $16.4M and bringing the position to 128,254 shares worth $41.3M. The position accounts for 0.02% of the portfolio, ranked #842.

American Century Companies first reported a position in PRAX in Q1 2024 and has held it in 6 quarters since. 289 funds tracked by Wall St. Rank hold PRAX as of Q1 2026.

• American Century Companies held 128,254 shares of Praxis Precision Medicines worth $41.3M as of Q1 2026.
• American Century Companies bought 52,888 Praxis Precision Medicines shares in Q1 2026, an estimated $16.4M.
• Praxis Precision Medicines made up 0.02% of American Century Companies's portfolio in Q1 2026, its #842 holding.
• American Century Companies first reported a position in Praxis Precision Medicines in Q1 2024 and has held it in 6 quarters since.
• 289 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q1 2026.

Based on American Century Companies's 13F filing for Q1 2026, filed 15 May 2026.